Kathrin Meyer Center for Gene Therapy The Research Institute at Nationwide Children’s Hospital Biography Publications Institution JoVE Articles Kathrin Meyer has not added a biography. If you are Kathrin Meyer and would like to personalize this page please email our Author Liaison for assistance. Publications Intracranial Delivery of AAV9 Gene Therapy Partially Prevents Retinal Degeneration and Visual Deficits in CLN6-Batten Disease Mice Molecular Therapy. Methods & Clinical Development. Mar, 2021 | Pubmed ID: 33665223 AAV9 Gene Therapy Increases Lifespan and Treats Pathological and Behavioral Abnormalities in a Mouse Model of CLN8-Batten Disease Molecular Therapy : the Journal of the American Society of Gene Therapy. 01, 2021 | Pubmed ID: 33010819 Gene Therapy Corrects Brain and Behavioral Pathologies in CLN6-Batten Disease Molecular Therapy : the Journal of the American Society of Gene Therapy. 10, 2019 | Pubmed ID: 31331814 AAV-mediated Follistatin Gene Therapy Improves Functional Outcomes in the TIC-DUX4 Mouse Model of FSHD JCI Insight. 11, 2018 | Pubmed ID: 30429376 Glia-neuron Interactions in Neurological Diseases: Testing Non-cell Autonomy in a Dish Brain Research. 02, 2017 | Pubmed ID: 26778174 The C9orf72 Protein Interacts with Rab1a and the ULK1 Complex to Regulate Initiation of Autophagy The EMBO Journal. 08, 2016 | Pubmed ID: 27334615 Major Histocompatibility Complex Class I Molecules Protect Motor Neurons from Astrocyte-induced Toxicity in Amyotrophic Lateral Sclerosis Nature Medicine. Apr, 2016 | Pubmed ID: 26928464 Improving Single Injection CSF Delivery of AAV9-mediated Gene Therapy for SMA - a Dose Response Study in Mice and Nonhuman Primates Molecular Therapy : the Journal of the American Society of Gene Therapy. Oct, 2014 | Pubmed ID: 25358252 Making Sense of Pain: Are Pluripotent Stem Cell-derived Sensory Neurons a New Tool for Studying Pain Mechanisms? Molecular Therapy : the Journal of the American Society of Gene Therapy. Aug, 2014 | Pubmed ID: 25082088 Therapeutic AAV9-mediated Suppression of Mutant SOD1 Slows Disease Progression and Extends Survival in Models of Inherited ALS Molecular Therapy : the Journal of the American Society of Gene Therapy. Dec, 2013 | Pubmed ID: 24008656 Transplantation of Gene-corrected Motor Neurons As a Therapeutic Strategy for Spinal Muscular Atrophy Molecular Therapy : the Journal of the American Society of Gene Therapy. Mar, 2013 | Pubmed ID: 23449105 Astrocytes from Familial and Sporadic ALS Patients Are Toxic to Motor Neurons Nature Biotechnology. Sep, 2011 | Pubmed ID: 21832997 In vitro Modeling for Neurological Diseases using Direct Conversion from Fibroblasts to Neuronal Progenitor Cells and Differentiation into Astrocytes Cassandra N. Dennys1, Julieth A. Sierra-Delgado1, Shrestha Sinha Ray1, Annalisa M. Hartlaub1, Florence S. Roussel1, Yacidzohara Rodriguez1, Kathrin Meyer1,2 1Center for Gene Therapy, The Research Institute at Nationwide Children’s Hospital, 2College of Medicine, The Ohio State University JoVE 62016 Neuroscience
In vitro Modeling for Neurological Diseases using Direct Conversion from Fibroblasts to Neuronal Progenitor Cells and Differentiation into Astrocytes Cassandra N. Dennys1, Julieth A. Sierra-Delgado1, Shrestha Sinha Ray1, Annalisa M. Hartlaub1, Florence S. Roussel1, Yacidzohara Rodriguez1, Kathrin Meyer1,2 1Center for Gene Therapy, The Research Institute at Nationwide Children’s Hospital, 2College of Medicine, The Ohio State University JoVE 62016 Neuroscience
